Cart
sales@molnova.com
Deferoxamine mesylate
CAS No. 138-14-7
Deferoxamine mesylate ( Desferrioxamine B mesylate;DFOM )
Catalog No. M11580 CAS No. 138-14-7
An iron chelator that binds iron and aluminium; increases HIF-1α transactivation in diabetes by preventing iron-catalyzed reactive oxygen stress.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 45 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDeferoxamine mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn iron chelator that binds iron and aluminium; increases HIF-1α transactivation in diabetes by preventing iron-catalyzed reactive oxygen stress.
-
DescriptionAn iron chelator that binds iron and aluminium; increases HIF-1α transactivation in diabetes by preventing iron-catalyzed reactive oxygen stress.Other Indication Approved
-
SynonymsDesferrioxamine B mesylate;DFOM
-
PathwayOthers
-
TargetOther Targets
-
RecptorAluminum;Iron
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number138-14-7
-
Formula Weight656.79
-
Molecular FormulaC26H52N6O11S
-
Purity>98% (HPLC)
-
SolubilityH2O: ≥ 33 mg/mL
-
SMILESCS(O)(=O)=O.CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
-
Chemical NameButanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Duscher D, et al. Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):94-9.
2. Miyajima H, et al. Ann Neurol. 1997 Mar;41(3):404-7.
3. Choi EY, et al. J Immunol. 2004 Jun 1;172(11):7069-77.
2. Miyajima H, et al. Ann Neurol. 1997 Mar;41(3):404-7.
3. Choi EY, et al. J Immunol. 2004 Jun 1;172(11):7069-77.
molnova catalog
related products
-
Peptide M
Peptide M is a synthetic Peptide, 50 aa, derived from streptococcus M protein, containing an additional c-terminal cysteine residue.
-
Chikusetsusaponin IV
Chikusetsusaponin IV might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.
-
KL-11743
KL-11743 specifically blocks glucose metabolism, triggering an acute collapse in NADH pools and a striking accumulation of aspartate, indicating a dramatic shift toward oxidative phosphorylation in the mitochondria.
